Agilvax

SBIR Awards $2.3 Million Grant to Agilvax to Advance Immunotherapy for Triple Negative Breast Cancer
CP Wire
Tue, 08/7/18 - 11:33 am
SBIR
Agilvax
NCI
AX09
SBIR Awards $2.3 Million Grant to Agilvax to Advance Immunotherapy for Triple Negative Breast Cancer
Tue, 08/7/18 - 09:59 am
Agilvax
AX09
breast cancer